Profiles

Keywords
Last Name
Institution

Connection

Mary Hayden to Escherichia coli

This is a "connection" page, showing publications Mary Hayden has written about Escherichia coli.

 
Connection Strength
 
 
 
1.218
 
  1. Hayden MK, Won SY. Carbapenem-Sparing Therapy for Extended-Spectrum ß-Lactamase-Producing E coli and Klebsiella pneumoniae Bloodstream Infection: The Search Continues. JAMA. 2018 09 11; 320(10):979-981.
    View in: PubMed
    Score: 0.741
  2. Lolans K, Calvert K, Won S, Clark J, Hayden MK. Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens. J Clin Microbiol. 2010 Mar; 48(3):836-41.
    View in: PubMed
    Score: 0.406
  3. Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, Miyashiro D, Quinn JP, Weinstein RA, Trenholme GM. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis. 1996 Sep; 174(3):529-36.
    View in: PubMed
    Score: 0.040
  4. Prabaker K, Lin MY, McNally M, Cherabuddi K, Ahmed S, Norris A, Lolans K, Odeh R, Chundi V, Weinstein RA, Hayden MK. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol. 2012 Dec; 33(12):1193-9.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.